Abstract

Objective: In this study, we aimed to investigate the effect of preoperative clinical status on the choice of anesthesia method and the postoperative maternal and fetal outcomes in the caesarean section of pregnant women with COVID-19 related acute respiratory distress syndrome.
 Materials and Methods: Pregnant women with COVID-19 related acute respiratory distress syndrome, for whom caesarean sections were planned, were included in this retrospective study. Clinical features, preoperative findings and treatments, maternal and fetal outcomes in the preoperative period, intensive care needs, and hospital stay were evaluated.
 Results: Ten patients who underwent caesarean section were included in the study. The mean age of the patients was 34±1.82 and the mean gestational week was 33.1±3.88. Chronic disease was present in 44.4% of them. Sixty percent of the patients were admitted to the postoperative intensive care unit. Eighty percent of the newborns were preterm and half of the newborns needed intensive care unit hospitalization.
 Conclusion: The clinical features of pregnant women with COVID-19 are similar to those reported for non-pregnant adults with COVID-19, but respiratory parameters of pregnant women with COVID-19 related acute respiratory distress syndrome deteriorate rapidly and should be monitored closely. Preoperative clinic status and oxygenation are the most important determinants in the selection of anesthesia type for the caesarean section.

Highlights

  • Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Healt Organization (WHO) [1]

  • We aimed to investigate the effect of preoperative clinical status on the choice of anesthesia method and postoperative maternal and fetal outcomes following caesarean section in COVID-19 possible pregnant women in the presence of COVID-19-related acute respiratory distress syndrome (ARDS)

  • The SARS-CoV-2 quantitative RT-PCR (polymerase chain reaction (PCR) test, rapid antibody test, and thorax tomography were used preoperatively to diagnose patients who had a history of contact and /or presented with COVID-19 symptoms

Read more

Summary

Introduction

Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Healt Organization (WHO) [1]. It was seen that all of these patients had a history of visiting Wuhan (Hubei, China) seafood and wild animal market. When the throat swab samples of the patients evaluated by the disease control committee of the People’s Republic of China were examined, the detected pathogen was called SARS Cov 2 virus, and the name of the disease was called COVID-19 by WHO. SARS Cov 2 has 85% similarity with other coronaviruses, such as SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) viruses. SARS and MERS viruses markedly caused poor fetal and maternal outcomes such as preterm birth, stillbirth, respiratory complications, and maternal mortality

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call